• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核结合作为阿霉素、柔红霉素、阿霉素醇、柔红霉素醇和放线菌素D组织分布的决定因素。

Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D.

作者信息

Terasaki T, Iga T, Sugiyama Y, Sawada Y, Hanano M

出版信息

J Pharmacobiodyn. 1984 May;7(5):269-77. doi: 10.1248/bpb1978.7.269.

DOI:10.1248/bpb1978.7.269
PMID:6470925
Abstract

The tissue distribution mechanism of adriamycin (ADR), its relatives, daunomycin (DNR), adriamycinol (ADR-ol), daunorubicinol (DNR-ol) and actinomycin D (ACT-D) has been studied in rats and rabbits. The following evidences with respect to tissue distribution of ADR were obtained: 1) remarkable binding of ADR to tissue homogenate, 2) significant difference in the tissue binding of ADR among tissues, 3) exclusive localization of ADR in cell nucleus, 4) good correlation between the tissue binding of ADR and the tissue desoxyribonucleic acid (DNA) concentration, 5) comparatively good coincidence between the experimentally determined tissue binding of ADR and that calculated from in vitro nuclear binding parameters reported and the tissue DNA concentration, and 6) no correlation between the concentration of tissue phospholipids (i.e. cardiolipin, acidic phospholipids and total phospholipids) and the Kp value of ADR in rats. From these findings, it was confirmed that the nuclear binding is a determinant of the extensive tissue distribution of ADR and that a remarkable variation in the tissue concentration of ADR is due mainly to the difference in the tissue DNA concentration. Furthermore, good correlations were demonstrated between the DNA concentration and Kpapp values of DNR and ACT-D in rats and DNR, ADR-ol and DNR-ol in rabbits. Hence, it is suggested that there is a common mechanism of in vivo tissue distribution of ADR and its relatives which can intercalate to DNA and the determinant of characteristic tissue distribution is nuclear binding of these antibiotics.

摘要

在大鼠和兔子身上研究了阿霉素(ADR)及其相关药物柔红霉素(DNR)、阿霉素醇(ADR-ol)、柔红霉素醇(DNR-ol)和放线菌素D(ACT-D)的组织分布机制。获得了以下关于ADR组织分布的证据:1)ADR与组织匀浆有显著结合;2)ADR在各组织间的组织结合存在显著差异;3)ADR在细胞核中特异性定位;4)ADR的组织结合与组织脱氧核糖核酸(DNA)浓度有良好相关性;5)实验测定的ADR组织结合与根据报道的体外核结合参数和组织DNA浓度计算得出的结果有较好的一致性;6)大鼠组织磷脂(即心磷脂、酸性磷脂和总磷脂)浓度与ADR的Kp值之间无相关性。从这些发现可以证实,核结合是ADR广泛组织分布的决定因素,ADR组织浓度的显著差异主要归因于组织DNA浓度的差异。此外,还证明了大鼠中DNR和ACT-D以及兔子中DNR、ADR-ol和DNR-ol的DNA浓度与Kpapp值之间有良好的相关性。因此,提示ADR及其相关药物在体内组织分布存在共同机制,这些药物可插入DNA,其特征性组织分布的决定因素是这些抗生素的核结合。

相似文献

1
Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D.核结合作为阿霉素、柔红霉素、阿霉素醇、柔红霉素醇和放线菌素D组织分布的决定因素。
J Pharmacobiodyn. 1984 May;7(5):269-77. doi: 10.1248/bpb1978.7.269.
2
Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
Biochim Biophys Acta. 1990 Nov 9;1036(2):121-7. doi: 10.1016/0304-4165(90)90023-p.
3
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
Biol Pharm Bull. 1996 Jan;19(1):100-5. doi: 10.1248/bpb.19.100.
4
Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Biol Pharm Bull. 1996 Jul;19(7):971-6. doi: 10.1248/bpb.19.971.
5
Distribution of daunorubicin intravenously injected or intravenously infused as free drug and as a complex with DNA in rabbits.柔红霉素以游离药物形式以及与DNA复合物形式静脉注射或静脉输注在兔体内的分布情况。
Pharmacology. 1982;24(4):253-60. doi: 10.1159/000137604.
6
Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.阿霉素和柔红霉素及其羟基代谢产物阿霉素醇和柔红霉素醇的反相液相色谱分析
J Chromatogr. 1978 Feb 11;149:225-32. doi: 10.1016/s0021-9673(00)80988-7.
7
Might adriamycinol contribute to adriamycin-induced cardiotoxicity?阿霉素醇会导致阿霉素引起的心脏毒性吗?
Pharmacol Res Commun. 1985 Nov;17(11):1073-84. doi: 10.1016/0031-6989(85)90113-4.
8
Pharmacokinetics of daunorubicinol in the rabbit: comparison with daunorubicin.柔红霉素醇在兔体内的药代动力学:与柔红霉素的比较。
J Pharmacol. 1986 Jan-Mar;17(1):14-20.
9
Transport mechanism of pirarubicin in human mononuclear cells.
Biol Pharm Bull. 1996 Sep;19(9):1203-9. doi: 10.1248/bpb.19.1203.
10
Cellular pharmocodynamics of several anthrocycline antibiotics.几种蒽环类抗生素的细胞药效学。
J Med Chem. 1976 May;19(5):651-4. doi: 10.1021/jm00227a015.

引用本文的文献

1
Interaction of anthraquinones of seeds with DNA and Glutathione.种子中蒽醌与DNA及谷胱甘肽的相互作用。
Toxicol Rep. 2018 Jan 3;5:164-172. doi: 10.1016/j.toxrep.2017.12.024. eCollection 2018.
2
Crossing the barrier: treatment of brain tumors using nanochain particles.跨越障碍:使用纳米链颗粒治疗脑肿瘤
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Sep;8(5):678-95. doi: 10.1002/wnan.1387. Epub 2016 Jan 9.
3
Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.使用链式纳米颗粒治疗侵袭性脑肿瘤。
Cancer Res. 2015 Apr 1;75(7):1356-65. doi: 10.1158/0008-5472.CAN-14-1540. Epub 2015 Jan 27.
4
Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.采用多组分链式纳米粒子治疗癌症微转移。
J Control Release. 2014 Jan 10;173:51-8. doi: 10.1016/j.jconrel.2013.10.031. Epub 2013 Nov 2.
5
Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.利用具有射频可调药物释放的多组分纳米链增强化疗药物向肿瘤的递送。
ACS Nano. 2012 May 22;6(5):4157-68. doi: 10.1021/nn300652p. Epub 2012 Apr 13.
6
Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.在临床相关阿霉素浓度下通过加速器质谱法检测阿霉素 - DNA加合物
Nucleic Acids Res. 2008 Sep;36(16):e100. doi: 10.1093/nar/gkn439. Epub 2008 Jul 16.
7
Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.阿霉素及阿霉素醇在兔体内推注和持续输注阿霉素后的药代动力学及组织浓度
Cancer Chemother Pharmacol. 1993;32(1):53-8. doi: 10.1007/BF00685876.
8
Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites.多柔比星以协同方式与心肌细胞结合。有两个结合位点。
Cancer Chemother Pharmacol. 1986;17(3):241-6. doi: 10.1007/BF00256692.